Clinical trials
Serum clinical trials
Below are recruiting serum clinical trials, each written for real people, not researchers. We’re tracking 190 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06339489Recruiting
Bone Health in Early Menopause Study
This study looks at how bone health changes in women with premature ovarian insufficiency (early menopause). It aims to understand the body's bone metabolism to help manage long-term health.
BeijingAges 18–39 - NCT06383182Recruiting
Study of blood markers after stroke artery treatment
This study looks at how certain proteins in the blood change after a procedure to remove a large blockage in a brain artery. The goal is to better understand recovery after stroke treatment.
ShenyangAges 18–80 - NCT06409949Recruiting
MitoQ for leg pain from blocked arteries
This study tests whether MitoQ, a supplement that protects cells, can improve leg pain and walking ability in people with peripheral artery disease. It aims to see if it helps the tiny blood vessels and muscle fibers in the leg.
Omaha, NebraskaAges 21 years+ - NCT06475118Recruiting
Blood tests and scans to measure muscle loss in liver cancer
This study looks at whether measuring certain proteins in your blood (myokines) can help detect muscle loss (sarcopenia) in people with liver cancer, and compares these blood tests to special CT scans. If you're newly diagnosed with liver cancer and have a CT scan already, you may be able to join.
ReimsAges 18 years+ - NCT06486909Recruiting
Shunt need after brain aneurysm bleed: role of early high blood sugar
This study looks at whether high blood sugar levels early after a brain aneurysm bleed affect the need for a shunt (a tube to drain fluid from the brain). It aims to help doctors understand who might need this treatment.
AarauAges 18 years+ - NCT06513611Recruiting
Immune and hormone markers in acute coronary syndrome prognosis
This trial looks at how your body's immune system, hormones, and inflammation affect recovery after a heart attack or unstable angina. It may help doctors better predict outcomes for people with acute coronary syndrome.
Buenos AiresAges 21 years+ - NCT06525688Recruiting
Osteoporosis study using bone tissue to find new targets
This study looks for new markers and treatment targets for osteoporosis by comparing bone tissue from women with a broken hip (due to weak bones) and women getting a hip replacement for arthritis. You may be eligible if you are postmenopausal and have one of these hip conditions.
Kifissia, AtticaAges Any age - NCT06545994Recruiting
Studying kisspeptin hormone levels in PCOS pregnancy
This study looks at a hormone called kisspeptin in pregnant women with PCOS. It aims to understand how this hormone changes during pregnancy, which may help improve care for women with PCOS.
Shanghai, Shanghai MunicipalityAges 18–40 - NCT06550622Recruiting
Better Detection of Hepatitis B Virus After Treatment
This study looks at a new way to detect the hepatitis B virus in the blood, even after standard tests say it's gone. It may help people who have stopped treatment and want to see if the virus comes back.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT06553313Recruiting
Knee pain study for adults over 50
This study looks at proteins in the blood to understand knee health. It is for adults over 50 who do not have knee pain.
TaichungAges 50 years+ - NCT06568926Recruiting
Adherence to Oral Chelation in Beta Thalassemia
This study checks how well children with beta thalassemia stick to their daily oral chelation pill (deferasirox). It aims to find ways to help them take it more regularly, improving iron control and reducing complications.
SohagAges 2–18 - NCT06615960Recruiting
Testing a snake antivenom for snakebite victims
This trial tests a snake antivenom called PANAF-Premium to see if it is safe and works well for people bitten by snakes. It is for anyone with signs of venom poisoning, and you can join even if you have had other snakebite treatments or are pregnant.
Garoua, North RegionAges Any age - NCT06629116Recruiting
Albumin treatment for large strokes after thrombectomy
This trial tests if giving a protein called albumin after a large stroke can improve recovery. Albumin may help reduce brain swelling and damage. You may qualify if you had a large stroke in the front part of the brain, got a clot-removal procedure, and meet certain age and health criteria.
Zhangzhou, FujianAges 18–80 - NCT06649474Recruiting
Oxaliplatin side effects linked to HMGB1 blood levels
This study checks if a substance called HMGB1 in your blood is linked to nerve damage and liver side effects from the chemotherapy drug oxaliplatin. It is for people with a specific type of stomach or pancreas cancer that can be surgically removed.
Clermont-FerrandAges 18 years+ - NCT06663111Recruiting
Rituximab and Ocrelizumab levels in Multiple Sclerosis
This trial looks at two medicines, rituximab and ocrelizumab, in the blood of people with multiple sclerosis. It only includes people who are already in another study called OVERLORD-MS and can give blood samples on a schedule.
Bergen, VestlandAges 18–60 - NCT06669000Recruiting
How long to dissolve gout crystals
This study looks at how long it takes for urate crystals (the cause of gout) to dissolve in the body. It may help if you have gout, are not on uric acid-lowering medicine, and have higher uric acid levels.
ParisAges 18 years+ - NCT07682935Recruiting
Fishing therapy for schizophrenia: mood and quality of life
This study tests if fishing, as a supportive therapy, can help people with schizophrenia improve mood, reduce anxiety, and boost quality of life. It looks at changes in blood markers and well-being.
Elâzığ, CenterAges 18–60 - NCT04968964Recruiting
Monitoring test for CDK4/6 drugs in metastatic breast cancer
This study follows people with hormone receptor–positive, HER2-negative metastatic breast cancer who are taking CDK4/6 inhibitor treatment (with or without an added blood test called DiviTum®). The goal is to see how well the standard treatment is working and whether DiviTum® (a serum TK1 activity test) can help guide monitoring.
St Louis, MissouriAges 18 years+ - NCT06742060Recruiting
Copeptin levels after brain surgery in children
This study follows children after brain surgery to see how a substance called copeptin (a marker in the blood) changes and whether it can help doctors spot a condition that causes too much thirst and urination (diabetes insipidus) early. It may lead to better care for children in the ICU.
Shanghai, Shanghai MunicipalityAges 4 weeks–18 years - NCT06748365Recruiting
Ferritin levels and recovery in diabetic ketoacidosis
This study looks at whether the level of a protein called ferritin in your blood can help predict how well you recover from diabetic ketoacidosis (DKA). If you have DKA and are over 18, you may be able to join.
Sohag, Sohag GovernorateAges 18 years+ - NCT06768840RecruitingPhase 2/Phase 3
New treatment for active vitiligo, checking blood markers
This trial tests a new treatment for people with active generalized vitiligo covering more than 5% of their body (not counting hands and feet). It also looks at a protein in the blood called s100B to see how it relates to the condition and treatment response.
QinaAges 10–75 - NCT06793085Recruiting
Inflammation Proteins in PCOS Study
This study looks at inflammation-related proteins in women with PCOS to understand what causes the condition. If eligible, you’d help researchers learn more about PCOS, which could lead to better treatments.
KrakowAges 18–45 - NCT06830551Recruiting
Cord blood serum eye drops for severe eye problems from anti-EGFR treatment
This trial tests whether cord blood serum eye drops can help with severe dry eye or corneal damage caused by anti-EGFR cancer treatment. If you have advanced cancer with an EGFR mutation and are struggling with eye irritation or vision problems from your medication, this study might offer a new way to help.
BolognaAges 18 years+ - NCT06843707Recruiting
Lung nodule study using blood and tissue metabolism
This trial follows people with lung nodules over time, using blood and tissue samples to look for metabolic changes that may help understand lung cancer better. If you have a lung nodule found on a CT scan and can safely do lung function tests, this study may be a fit.
Guangzhou, GuangdongAges 18–75
Hear when a new Serum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for serum?
- Yes. Clin2 currently lists 190 recruiting serum studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a serum trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a serum trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.